ArticleFuture healthcare journal2025
Why addressing conflicts of interest is essential to progress in reducing commercially driven health harms: Lessons from tobacco.
Article in Future healthcare journal, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
4 citing papers in PubMed.
- Policy Progress in Using Economic Policy Instruments to Improve Nutrition: Challenges and Opportunities.Health economics · 2026Review
- Which types of research and knowledge translation are most likely to lead to public health-informed policy responses to unhealthy commodities? A UK-based cross-sectional survey and focus group-based study.BMJ public health · 2026Article
- If commercial incentives are the engine, then conflicts of interest are the lubricant.Future healthcare journal · 2025Article
- U.S. policy on wireless technologies and public health protection: regulatory gaps and proposed reforms.Frontiers in public health · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Globally and in the UK, significant progress has been made in tackling the harms of tobacco use. This was enabled by addressing the fundamental conflict between the tobacco industry's interests and those of the public, including by rejecting partnerships with the tobacco industry. Conflicts of interest (COIs), like those identified in tobacco control, exist in other areas of public health, yet governments, including the UK, continue to work in partnership with other health-harming industries, including alcohol, ultra-processed food and gambling, despite evidence that partnership approaches where COIs exist are ineffective. This article details lessons that can be drawn from this experience, outlining how understanding and addressing COIs in policy, professional practice and science are prerequisites to tackling commercially driven harms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.